These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30999771)

  • 21. Current and emerging therapies for Alzheimer's disease.
    Nygaard HB
    Clin Ther; 2013 Oct; 35(10):1480-9. PubMed ID: 24139420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review on Alzheimer's disease pathophysiology and its management: an update.
    Kumar A; Singh A; Ekavali
    Pharmacol Rep; 2015 Apr; 67(2):195-203. PubMed ID: 25712639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanotechnology in Personalized Medicine: A Promising Tool for Alzheimer's Disease Treatment.
    De Matteis L; Martín-Rapún R; de la Fuente JM
    Curr Med Chem; 2018; 25(35):4602-4615. PubMed ID: 29022501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium.
    Seripa D; Solfrizzi V; Imbimbo BP; Daniele A; Santamato A; Lozupone M; Zuliani G; Greco A; Logroscino G; Panza F
    Expert Rev Neurother; 2016; 16(3):259-77. PubMed ID: 26822031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?
    Imbimbo BP; Panza F; Frisardi V; Solfrizzi V; D'Onofrio G; Logroscino G; Seripa D; Pilotto A
    Expert Opin Investig Drugs; 2011 Mar; 20(3):325-41. PubMed ID: 21222550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Alzheimer's disease: current status and new perspectives.
    Scarpini E; Scheltens P; Feldman H
    Lancet Neurol; 2003 Sep; 2(9):539-47. PubMed ID: 12941576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-potent Natural Scaffolds Targeting Amyloid Cascade: In Search of Alzheimer's Disease Therapeutics.
    Chakraborty S
    Curr Top Med Chem; 2017; 17(31):3336-3348. PubMed ID: 29345580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging chemical therapies targeting 5-hydroxytryptamine in the treatment of Alzheimer's disease.
    Calhoun A; Ko J; Grossberg GT
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):101-105. PubMed ID: 28253832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current pharmacotherapy for Alzheimer's disease.
    Lleó A; Greenberg SM; Growdon JH
    Annu Rev Med; 2006; 57():513-33. PubMed ID: 16409164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Research progress on natural products from traditional Chinese medicine in treatment of Alzheimer's disease.
    Gao J; Inagaki Y; Li X; Kokudo N; Tang W
    Drug Discov Ther; 2013 Apr; 7(2):46-57. PubMed ID: 23715502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer's disease: A review.
    Jiang Y; Gao H; Turdu G
    Bioorg Chem; 2017 Dec; 75():50-61. PubMed ID: 28915465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-amyloid treatments in Alzheimer's disease.
    Sapra M; Kim KY
    Recent Pat CNS Drug Discov; 2009 Jun; 4(2):143-8. PubMed ID: 19519562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-Target-Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer's Disease Therapy: Advances in Chemical and Biological Research.
    Jankowska A; Wesolowska A; Pawlowski M; Chlon-Rzepa G
    Curr Med Chem; 2018; 25(17):2045-2067. PubMed ID: 28554324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy of Alzheimer's disease: current and future trends.
    Geldenhuys WJ; Darvesh AS
    Expert Rev Neurother; 2015 Jan; 15(1):3-5. PubMed ID: 25481975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Snapshot on the Current Status of Alzheimer's Disease, Treatment Perspectives, in-Vitro and in-Vivo Research Studies and Future Opportunities.
    Tezel G; Timur SS; Bozkurt İ; Türkoğlu ÖF; Eroğlu İ; Nemutlu E; Öner L; Eroğlu H
    Chem Pharm Bull (Tokyo); 2019 Oct; 67(10):1030-1041. PubMed ID: 31341111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Alzheimer's disease-An insight of the enzymatic and other novel potential targets.
    Islam BU; Tabrez S
    Int J Biol Macromol; 2017 Apr; 97():700-709. PubMed ID: 28111296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developments with multi-target drugs for Alzheimer's disease: an overview of the current discovery approaches.
    González JF; Alcántara AR; Doadrio AL; Sánchez-Montero JM
    Expert Opin Drug Discov; 2019 Sep; 14(9):879-891. PubMed ID: 31165654
    [No Abstract]   [Full Text] [Related]  

  • 38. Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets.
    Khan A; Corbett A; Ballard C
    Expert Rev Neurother; 2017 Jul; 17(7):683-695. PubMed ID: 28490260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products.
    Yi L; Liu W; Wang Z; Ren D; Peng W
    Ann N Y Acad Sci; 2017 Jun; 1398(1):130-141. PubMed ID: 28632966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotechnology solutions for Alzheimer's disease: advances in research tools, diagnostic methods and therapeutic agents.
    Nazem A; Mansoori GA
    J Alzheimers Dis; 2008 Mar; 13(2):199-223. PubMed ID: 18376062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.